Filing Flows › Rapid Micro Biosystems (RPID) › R&D spending
Rapid Micro Biosystems (RPID) R&D spending by quarter
Rapid Micro Biosystems' R&D spending was $3.3M in Q2 2026 (second quarter 2026), -0.8% from Q1 2026. Over the last 7 quarters it ranged from $3.2M (Q4 2025) to $3.6M (Q1 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $3.3M | -0.8% | +3% |
| Q1 2026 | $3.4M | +4% | -7% |
| Q4 2025 | $3.2M | -9% | -5% |
| Q3 2025 | $3.5M | +9% | — |
| Q2 2025 | $3.2M | -11% | — |
| Q1 2025 | $3.6M | +7% | — |
| Q4 2024 | $3.4M | — | — |
Q2 2026 at a glance
Rapid Micro Biosystems, Q2 2026: revenue $8.1M (+11% year over year), operating margin -153.0%, net loss $12.9M, operating cash flow −$12.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Rapid Micro Biosystems' R&D spending?
Rapid Micro Biosystems' R&D spending was $3.3M in Q2 2026 (second quarter 2026), -0.8% from Q1 2026.
How has Rapid Micro Biosystems' R&D spending changed?
Over the last 7 quarters it ranged from $3.2M (Q4 2025) to $3.6M (Q1 2025).
Q2 2026 results → · How Rapid Micro Biosystems makes money →